Profound Medical (PROF)
(Delayed Data from NSDQ)
$8.03 USD
0.00 (0.00%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $8.17 +0.14 (1.74%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Price, Consensus and EPS Surprise
PROF 8.03 0.00(0.00%)
Will PROF be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for PROF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PROF
Profound Medical (PROF), Siemens Unite to Treat Prostate Cancer
Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lags Revenue Estimates
PROF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Profound Medical (PROF) Soars 9.4%: Is Further Upside Left in the Stock?
How Much Upside is Left in Profound Medical (PROF)? Wall Street Analysts Think 66.06%
Strength Seen in Profound Medical (PROF): Can Its 19.5% Jump Turn into More Strength?
Other News for PROF
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
Profound Medical Unveils Q1 2024 Financials
Profound Medical Announces Q1 2024 Results Release
Profound Medical to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference
Profound Medical to Present at Healthcare Investor Conference